Mugdha Srivastava

554 total citations
33 papers, 383 citations indexed

About

Mugdha Srivastava is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mugdha Srivastava has authored 33 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Mugdha Srivastava's work include vaccines and immunoinformatics approaches (5 papers), Plant-Microbe Interactions and Immunity (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Mugdha Srivastava is often cited by papers focused on vaccines and immunoinformatics approaches (5 papers), Plant-Microbe Interactions and Immunity (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Mugdha Srivastava collaborates with scholars based in Germany, India and United Kingdom. Mugdha Srivastava's co-authors include Shishir K. Gupta, Shailendra K. Gupta, Bashir Akhlaq Akhoon, Thomas Dandekar, P.C. Abhilash, Muhammad Naseem, Muhammad Tehseen, N. P. Singh, Archana Singh and Elena Bencúrová and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Mugdha Srivastava

31 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mugdha Srivastava Germany 13 213 83 68 62 56 33 383
Klára Kubelková Czechia 12 174 0.8× 35 0.4× 64 0.9× 41 0.7× 66 1.2× 36 356
Sameer Hassan India 12 210 1.0× 103 1.2× 96 1.4× 107 1.7× 36 0.6× 42 444
Yingnian Lu China 10 171 0.8× 90 1.1× 41 0.6× 33 0.5× 103 1.8× 23 456
Miren Josu Omaetxebarria Ibarra Spain 11 180 0.8× 152 1.8× 180 2.6× 30 0.5× 60 1.1× 19 432
Samuel Rulli United States 7 267 1.3× 86 1.0× 99 1.5× 58 0.9× 52 0.9× 15 442
Yilei Yang China 12 157 0.7× 60 0.7× 92 1.4× 27 0.4× 56 1.0× 35 423
Assirbad Behura India 11 200 0.9× 97 1.2× 102 1.5× 43 0.7× 178 3.2× 17 472
Andreas Roth Germany 9 289 1.4× 100 1.2× 113 1.7× 32 0.5× 154 2.8× 12 532
Muhammad Shahab China 11 207 1.0× 55 0.7× 53 0.8× 20 0.3× 32 0.6× 45 306
Wenqi Dong China 12 105 0.5× 105 1.3× 140 2.1× 17 0.3× 40 0.7× 36 333

Countries citing papers authored by Mugdha Srivastava

Since Specialization
Citations

This map shows the geographic impact of Mugdha Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mugdha Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mugdha Srivastava more than expected).

Fields of papers citing papers by Mugdha Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mugdha Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mugdha Srivastava. The network helps show where Mugdha Srivastava may publish in the future.

Co-authorship network of co-authors of Mugdha Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Mugdha Srivastava. A scholar is included among the top collaborators of Mugdha Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mugdha Srivastava. Mugdha Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herrmann, Marietta, S Wiesner, Maximilian Rudert, et al.. (2024). Peripheral blood cells enriched by adhesion to CYR61 are heterogenous myeloid modulators of tissue regeneration with early endothelial progenitor characteristics. European Cells and Materials. 48. 66–92.
2.
Srivastava, Mugdha, et al.. (2024). A focus on c-Jun-N-terminal kinase signaling in sepsis-associated multiple organ dysfunction: Mechanisms and therapeutic strategies. International Immunopharmacology. 143(Pt 3). 113552–113552. 6 indexed citations
3.
García‐Romero, Inmaculada, et al.. (2024). Drug efflux and lipid A modification by 4-L-aminoarabinose are key mechanisms of polymyxin B resistance in the sepsis pathogen Enterobacter bugandensis. Journal of Global Antimicrobial Resistance. 37. 108–121. 4 indexed citations
4.
Gupta, Shishir K., et al.. (2023). Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection. Frontiers in Immunology. 14. 1285345–1285345. 1 indexed citations
5.
Burkard, Natalie, Thomas Dandekar, Mugdha Srivastava, et al.. (2023). Endothelial barrier dysfunction in systemic inflammation is mediated by soluble VE-cadherin interfering VE-PTP signaling. iScience. 26(10). 108049–108049. 9 indexed citations
6.
Frings, Verena, et al.. (2022). Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology. 36(12). 2488–2498. 12 indexed citations
7.
Srivastava, Mugdha, et al.. (2022). CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma. Cell Death Discovery. 8(1). 505–505. 7 indexed citations
8.
Delgobo, Murilo, Mugdha Srivastava, Tobias Heckel, et al.. (2021). Terminally Differentiated CD4+ T Cells Promote Myocardial Inflammaging. Frontiers in Immunology. 12. 584538–584538. 24 indexed citations
9.
10.
Srivastava, Mugdha, et al.. (2019). Aspergillus fumigatus Challenged by Human Dendritic Cells: Metabolic and Regulatory Pathway Responses Testify a Tight Battle. Frontiers in Cellular and Infection Microbiology. 9. 168–168. 18 indexed citations
11.
Srivastava, Mugdha, Shishir K. Gupta, Chunguang Liang, et al.. (2016). Systematic Identification of Anti-Fungal Drug Targets by a Metabolic Network Approach. Frontiers in Molecular Biosciences. 3. 22–22. 32 indexed citations
12.
Naseem, Muhammad, Mugdha Srivastava, & Thomas Dandekar. (2014). Stem-cell-triggered immunity safeguards cytokinin enriched plant shoot apexes from pathogen infection. Frontiers in Plant Science. 5. 588–588. 2 indexed citations
13.
López, Daniel, et al.. (2013). A semi-quantitative model of Quorum-Sensing in Staphylococcus aureus , approved by microarray meta-analyses and tested by mutation studies. Molecular BioSystems. 9(11). 2665–2680. 12 indexed citations
14.
Srivastava, Mugdha, P.C. Abhilash, & Nandita Singh. (2011). Remediation of Lindane Using Engineered Nanoparticles. Journal of Biomedical Nanotechnology. 7(1). 172–174. 13 indexed citations
15.
Malviya, Neha, et al.. (2011). Insights to Sequence Information of Polyphenol Oxidase Enzyme from Different Source Organisms. Applied Biochemistry and Biotechnology. 165(2). 397–405. 14 indexed citations
16.
Gupta, Shishir K., Shishir K. Gupta, A. Sarangi, et al.. (2010). In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development. Vaccine. 28(43). 7092–7097. 30 indexed citations
17.
Gupta, Shishir K., Shishir K. Gupta, Mugdha Srivastava, et al.. (2010). Identification of immunogenic consensus T-cell epitopes in globally distributed influenza-A H1N1 neuraminidase. Infection Genetics and Evolution. 11(2). 308–319. 24 indexed citations
18.
Srivastava, Mugdha, Bashir Akhlaq Akhoon, Shishir K. Gupta, & Shailendra K. Gupta. (2010). Development of resistance against blackleg disease in Brassica oleracea var. botrytis through in silico methods. Fungal Genetics and Biology. 47(10). 800–808. 8 indexed citations
19.
Gupta, Shishir K., Shishir K. Gupta, Archana Singh, et al.. (2009). In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer. Vaccine. 28(1). 120–131. 25 indexed citations
20.
Kumar, Arvind, et al.. (2000). Pathogenic variability of Xanthomonas oryzae pv. oryzae.. Indian Phytopathology. 53(1). 19–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klára Kubelková Breakdown of academic impact, for papers by Sameer Hassan Breakdown of academic impact, for papers by Yingnian Lu Breakdown of academic impact, for papers by Miren Josu Omaetxebarria Ibarra Breakdown of academic impact, for papers by Samuel Rulli Breakdown of academic impact, for papers by Yilei Yang Breakdown of academic impact, for papers by Assirbad Behura Breakdown of academic impact, for papers by Andreas Roth Breakdown of academic impact, for papers by Muhammad Shahab Breakdown of academic impact, for papers by Wenqi Dong
Rankless by CCL
2026